365Telugu.com online news,Mumbai, June 6th, 2025: Emcutix Biopharmaceuticals Ltd., a wholly owned subsidiary of Emcure Pharmaceuticals, has entered the dermatology space with the launch of its specialized anti-acne skincare range, Flawlizo Xpert Acne Care. Designed with a scientific and targeted approach, the Flawlizo range addresses various stages of acne with fast-acting, clinically validated formulations.
The product line features:
- Flawlizo Acne Spot Corrector – A powerful biphasic formula proven to visibly reduce early acne breakouts within 3–5 days.
- Flawlizo Acne Care Moisturizing Gel – A non-comedogenic, lightweight hydrator enriched with natural extracts, developed to nourish acne-prone skin without clogging pores.
This new range reflects Emcutix’s commitment to combining clinical efficacy with consumer-friendly skincare solutions. Designed for safe and effective daily use, Flawlizo offers a comprehensive approach to acne management, addressing breakouts, skin barrier repair, and hydration in a single regimen.
In addition to the consumer-facing products, the Flawlizo range also includes five prescription-only (℞) products formulated with Tretinoin, a globally recognized active ingredient sourced from Italy. These are manufactured at the USFDA-approved facility of Encube Ethicals Pvt. Ltd., known for being the world’s largest producer of pharmaceutical topical formulations.
Read This also…RCB vs PBKS Face Off in IPL 2025 Final Tonight..
ఇది కూడా చదవండి…హ్యుందాయ్ కొత్త ప్రచారం: పంకజ్ త్రిపాఠి తో ‘లిజన్ టు యువర్ దిల్ ఆర్ ది డీల్స్’..
Commenting on the launch, Sathya Narayanan, CEO of Emcutix Biopharmaceuticals, said:
“At Emcutix, we’re focused on delivering science-backed skincare that meets real-world needs. The Flawlizo range reflects our goal of providing dermatologist-recommended, accessible solutions for effective acne care across India.”
This launch marks a strategic expansion of Emcutix’s dermatology portfolio, which now spans prescription, aesthetic, and over-the-counter segments. The announcement follows Emcutix’s recent exclusive licensing agreement with WiQo, bringing the non-invasive skin treatment PRX-PLUS to India for the first time.
With Flawlizo, Emcutix aims to revolutionize acne care by offering reliable, fast-acting solutions grounded in science — setting a new benchmark in skincare for Indian consumers.